| Name | Title | Contact Details |
|---|
At 4Catalyzer we are transforming 21st century medicine by solving today’s most challenging problems – across life science tools, medical devices and therapeutics. We aspire to create significant societal impact and are motivated by the idea that our products will change the lives of people we love. We seek the talent of truly gifted, self-starting and driven individuals to help advance this mission. We provide a stimulating environment, surrounded by brilliant, highly committed individuals who are given both the autonomy and project ownership to solve difficult problems and be the first to publish. Each 4Catalyzer company endeavors to develop technologies that enable unprecedented looks at nature thereby affording the opportunity to do prize-winning science and publish in top-tier journals like Science and Nature. Our advisors have pioneered their fields. Our technology base includes truly novel Devices, Deep Learning and the Cloud. We understand that success requires surrounding yourself with the right people, being at the right place at the right time, and having the resources to get the job done.
1-800 Wheelchair.com is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bone Bank Allografts is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Belco Packaging Systems is a Monrovia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotrispy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. In peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, IVL demonstrated safety and consistent procedure success with low procedural complications. The technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatments. And because it is built on a traditional balloon catheter platform, it integrates seamlessly with clinicians` existing workflow.